Daryl Drummond

Company: Akagera Medicines

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Assessing Different Routes of Administration for Optimal Safety Profiles and Therapeutic Effects 1:45 pm

Experts in this panel discussion will delve into various routes of administration across topical, intramuscular, inhalation, intranodal, intranasal, intraocular, intratumoral, intravesical Assessing the effectiveness of each route of administration in delivering the desired therapeutic effect Evaluating the safety profile of different routes of administration, considering potential adverse effects and risks Considering the ease of administration…Read more

day: Day One

Modulating Immunogenicity at The Design Phase 9:00 am

Addressing immunogenicity at the design phase plays a crucial role in enhancing therapeutic outcomes and reducing adverse reactions. The design phase offers opportunities to optimize the selection and design of therapeutic targets, considering factors such as antigenicity and immune recognition. This session provides immune evasion strategies can be incorporated into the therapeutic intervention design, aimed…Read more

day: Pre-Conference Day Track A AM